You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 130 No. 4, April 1994 TABLE OF CONTENTS
  Archives
  •  Online Features
  Editorials
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Keratosis Pilaris Atrophicans

One Heterogeneous Disease or a Symptom in Different Clinical Entities?

Arnold P. Oranje, MD, PhD; Dr Molewaterplein; Loes D. M. van Osch, MD; Jan C. Oosterwijk, MD

Arch Dermatol. 1994;130(4):500-502.

Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

IN this issue of the ARCHIVES, Baden and Byers1 describe 21 cases of keratosis pilaris atrophicans (KPA). He considers KPA as one disease entity.1 However, our opinion differs in view of the arguments presented here. Keratosis pilaris (KP) is a skin symptom associated with different diseases, mostly of ectodermal origin. By definition, keratinous plugs are observed in the follicular orifices surrounded by a variable degree of erythema. When the keratotic papules are followed by atrophy, one speaks of KPA. Atrophy is preceded with or without inflammation. There is much confusion on KP and KPA entities, especially because different overlapping syndromes have been described and many synonyms are used in both dermatologic and genetic literature.2-4 In this editorial, we present our opinion and arguments on diseases with KPA.

KERATOSIS PILARIS ATROPHICANS

We distinguish four distinct clinical entities that show KPA. These are keratosis pilaris atrophicans faciei (KPAF), atrophoderma . . . [Full Text PDF of this Article]


Author Affiliations

Subdivision of Pediatric Dermatology University Hospital Rotterdam Sophia Children's Hospital; 60 3015 GJ Rotterdam, the Netherlands; Rotterdam Eye Hospital Rotterdam; Clinical Genetics Center Leiden, the Netherlands



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1994 American Medical Association. All Rights Reserved.